Aprepitant (emend) for prevention of nausea and vomiting due to cancer chemotherapy.
D000970:Antineoplastic Agents / Q000009:adverse effects; D000077608:Aprepitant; D004347:Drug Interactions / Q000502:physiology; D009025:Morpholines / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D009025:Morpholines; D000077608:Aprepitant